Dr. Azam Moosavi is a dedicated and innovative biochemist specializing in beta-cell regeneration for the treatment of Type 1 diabetes. With a strong academic foundation and a passion for interdisciplinary research, she integrates molecular biology, regenerative medicine, and clinical biochemistry in her scientific work. Over her academic and professional career, she has developed a notable track record in research, mentorship, and laboratory management. Her research aims to translate scientific findings into real-world applications, especially for chronic diseases like diabetes. She has contributed to several peer-reviewed publications, presented at major international conferences, and co-authored a book chapter on bioactive peptides. Currently serving as R&D and Cell Culture Lab Manager at the Innovation Center of Stem Cells and Regenerative Medicine at Tabriz University of Medical Sciences, Dr. Moosavi is also actively involved in mentoring young researchers. With additional expertise in teaching, clinical laboratory operations, and scientific writing, she brings a multifaceted approach to biomedical research. Her work demonstrates both academic rigor and practical impact, and she is highly regarded for her contributions to translational medicine, epigenetics, and molecular diagnostics. Dr. Moosavi continues to strive toward scientific excellence, combining curiosity with applied innovation in pursuit of better health solutions.
Professional Profile
Education
Dr. Azam Moosavi’s academic journey reflects her deep commitment to biomedical sciences and health research. She earned her Ph.D. in Biochemistry from the Institute of Biochemistry and Biophysics (IBB) at the University of Tehran, where her thesis focused on beta-cell regeneration in Type 1 diabetes through pharmaceutical induction. Her Ph.D. was marked by an impressive GPA (3.7/4) and resulted in multiple scientific presentations and publications. Prior to that, she completed a Master of Public Health (MPH) in Health Management and Reform at Tehran University of Medical Sciences, focusing on strategic risk management in health systems. She also holds an M.Sc. in Biochemistry from Tarbiat Moallem University in Tehran, where she investigated alpha thalassemia genetics, leading to multiple congress presentations. Dr. Moosavi began her academic training with a Bachelor of Science in Clinical Laboratory Sciences from Mashhad University of Medical Sciences, followed by an Associate degree in the same field from Tehran University of Medical Sciences. Her academic record is consistent, with GPA scores ranging from 3.3 to 3.9, showcasing a solid grasp of theory and practice. These multidisciplinary qualifications equip her with a robust foundation for both laboratory research and healthcare innovation.
Professional Experience
Dr. Moosavi brings over two decades of experience spanning research, laboratory management, and academic instruction. Since March 2023, she has served as R&D and Cell Culture Lab Manager at the Innovation Center of Stem Cells and Regenerative Medicine (SCARM), Tabriz University of Medical Sciences. Here, she supervises experimental design, oversees lab operations, mentors postgraduates, and contributes to cutting-edge regenerative research. Prior to this role, Dr. Moosavi spent ten years teaching biochemistry laboratory courses to medical, dental, and pharmacy students at Alborz University of Medical Sciences. Her instruction emphasized clinical applications and hands-on skills, significantly enhancing student competency in diagnostics. Between 2005 and 2013, she managed clinical laboratories in various health centers and at Kasra Hospital in Karaj, where she was responsible for quality control, team supervision, and staff training across hematology, microbiology, and biochemistry divisions. In addition to her formal roles, she has led workshops in quality control and hematology testing, implemented risk management strategies, and participated in numerous clinical and academic projects. Her professional journey is characterized by leadership in education, hands-on expertise in diagnostics, and a drive to integrate innovative research with public health practice.
Research Interests
Dr. Moosavi’s research interests are centered on the intersection of molecular biology, regenerative medicine, and clinical diagnostics. Her primary focus is on beta-cell regeneration as a therapeutic strategy for Type 1 diabetes—a condition she explores through pharmaceutical, genetic, and immunological lenses. She is particularly interested in cell-based models, gene regulatory networks, and high-tech therapeutic interventions aimed at reversing or halting disease progression. Her passion for stem cell biology and regenerative therapies is reflected in her involvement with mesenchymal stem cell research and the use of exosomes in clinical settings. Beyond diabetes, she has contributed to projects involving autoimmune disorders, fertility research, cancer diagnostics, and infectious diseases like COVID-19. Her work also explores epigenetic regulation, as evidenced by a highly cited publication on the role of epigenetics in human diseases. In addition, Dr. Moosavi is eager to integrate new technologies into her research, including artificial intelligence (AI), next-generation sequencing (NGS), and gene editing techniques. This interdisciplinary approach allows her to not only study disease mechanisms at the molecular level but also develop actionable, personalized treatment strategies. She continuously expands her research portfolio with a strong commitment to innovation and translational impact.
Research Skills
Dr. Moosavi has cultivated a wide array of research skills that span molecular techniques, computational analysis, and laboratory management. She is proficient in essential molecular biology methods including PCR, ELISA, Western blotting, and routine clinical laboratory testing. Her expertise also includes cell culture, particularly in managing regenerative medicine labs, as well as conducting experiments on the apoptotic effects of compounds and stem cell secretome applications. In addition to wet-lab skills, she is experienced in data analysis and literature management using tools like GraphPad Prism, RevMan5, and EndNote. Her training in Good Clinical Practice (GCP) and Good Manufacturing Practice (GMP) principles supports her ability to implement and monitor high-quality standards in laboratory settings. Moreover, she is well-versed in risk management using Failure Mode and Effects Analysis (FMEA), which she has applied to improve safety and operational efficiency in academic laboratories. With intermediate proficiency in English and basic command of German and Azerbaijani, she is also equipped for international collaboration. Altogether, her technical and analytical competencies allow her to conduct research that is both scientifically rigorous and aligned with current regulatory standards.
Awards and Honors
Dr. Azam Moosavi has received several notable recognitions throughout her academic and professional journey. She secured third place nationally in the Ph.D. entrance exam for biochemistry at the University of Tehran, reflecting her strong academic standing. Her contributions to the field of molecular biology and regenerative medicine have been acknowledged at prestigious conferences, including the Best Poster Award at the 17th National and 8th International Congress of Biochemistry and Molecular Biology in 2023. Additionally, she was selected as the first presenter in the Young Researchers’ Section at the 15th International & 21st National Congress on Quality Improvement in Clinical Laboratories in 2024. Beyond academic accolades, Dr. Moosavi holds a patent related to lung cancer antibody production using nanopharmaceutical technology, underscoring her innovation in translational research. She also earned third position in the National Industrial Innovation Competition, further recognizing her role in applied scientific development. These honors validate her dedication to excellence, whether in academic research, laboratory innovation, or public health impact. Collectively, these awards demonstrate Dr. Moosavi’s significant contributions to biomedical science and affirm her as a rising leader in the fields of biochemistry and regenerative medicine.
Conclusion
Dr. Azam Moosavi emerges as a well-qualified candidate for the Best Researcher Award, with extensive contributions to biochemistry, regenerative medicine, and clinical laboratory science. Her academic credentials, professional experience, and interdisciplinary research projects collectively demonstrate excellence in both theoretical and applied science. Through her focus on beta-cell regeneration for Type 1 diabetes, Dr. Moosavi has tackled a major public health challenge using innovative and translational approaches. Her record includes numerous peer-reviewed publications, international presentations, patents, and awards, positioning her as a leader in her field. She has also played a key role in education and mentorship, nurturing the next generation of biomedical researchers. With solid research skills, an expanding network of collaborations, and a commitment to continuous learning, Dr. Moosavi has built a career marked by impact, growth, and forward-thinking science. Moving forward, she is poised to make even greater contributions through high-impact research, interdisciplinary teamwork, and international engagement. Her profile exemplifies the qualities that the Best Researcher Award seeks to honor: intellectual rigor, practical innovation, and a drive to improve human health through science.
Publications Top Notes
-
Beta Cell Regeneration upon Magainin and Growth Hormone Treatment as a Possible Alternative to Insulin Therapy
Journal: FEBS Open Bio, 2023
Authors: Azam Moosavi, Razieh Yazdanparast
-
Human Herpesvirus 6 Infection and Risk of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis
Journal: Intervirology, 2022
Author: Azam Moosavi
-
A Systematic Review and Meta-Analysis on the Epidemiology, Causal Agents and Demographic Characteristics of Onychomycosis in Iran
Journal: Medical Mycology, 2019
Author: Azam Moosavi
-
Environmental Exposure to Endotoxin and Its Health Outcomes: A Systematic Review
Journal: Ecotoxicology and Environmental Safety, 2019
Author: Azam Moosavi
-
The Frequency of Fungi Isolated from the Skin and Hair of Asymptomatic Cats in Rural Area of Meshkin-shahr, Iran
Journal: Journal de Mycologie Médicale, 2019
Authors: A. Moosavi, R.D. Ghazvini, K. Ahmadikia, S.J. Hashemi, M. Geramishoar, M. Mohebali, M.S. Yekaninejad, H. Bakhshi, M. Khodabakhsh
-
The Frequency and Importance of Common α-globin Gene Deletions among β-thalassemia Carriers in an Iranian Population
Journal: Avicenna Journal of Medical Biotechnology, 2017
Authors: A. Moosavi, A.M. Ardekani
-
Role of Epigenetics in Biology and Human Diseases
Journal: Iranian Biomedical Journal, 2016
Author: Azam Moosavi
-
Bioactive Peptides
Publisher: CRC Press, 2021
Author: Azam Moosavi
-
Effect of Vitamin B6 Supplementation on Biochemical Values in Type 2 Diabetes Mellitus
Conference: Congress on Quality Improvement in Clinical Laboratories, 2015
Author: Azam Moosavi